SCHEMBL29814922

CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.61

▸	NPY4R	P50391	8/20	0.61

▸	NPY5R	Q15761	8/20	0.61

▸	NPY1R	P25929	6/20	0.61

▸	EP300	Q09472	1/20	0.58

▸	HIF1A	Q16665	1/20	0.58

▸	CALCR	P30988	5/20	0.56

▸	RAMP3	O60896	1/20	0.55

▸	F2	P00734	4/20	0.55

▸	OPRM1	P35372	1/20	0.51

▸	OPRD1	P41143	1/20	0.51

▸	OPRK1	P41145	1/20	0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30176506	0.86	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30432136	0.86	F2 (0.64)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30824291	0.84	CALCR (0.57)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL29640709	0.84	NPY2R (0.54)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30607381	0.84	NPY2R (0.68)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30495658	0.84	NPY2R (0.59)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL31000876	0.84	CALCR (0.61)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL29973255	0.84	NPY2R (0.62)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30648455	0.83	EP300 (0.64)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30567788	0.83	EP300 (0.58)	NPY2RNPY4RNPY5RNPY1REP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220242964-A1	COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION	2022-08-04	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20220242964-A1	COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS	EPOR, CD47, CD44	NPY2R 2869/4885NPY4R 2616/4885NPY5R 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.